| DAA1523 |
pre B-cell leukemia transcription factor 2 |
Molecular |
liver |
Mouse |
Pbx2 |
28.0% Increase Gene Expression Level |
|
| DAA844 |
Postprandial serum bile acids decrease |
Physiological |
alimentary system |
Human |
— |
— |
|
| DAA851 |
Peristaltic amplitude is diminished |
Physiological |
oropharynx, oesophagus |
Human |
— |
— |
|
| DAA851 |
Peristaltic amplitude is diminished |
Physiological |
oropharynx, oesophagus |
Human |
— |
— |
|
| DAA1509 |
perilipin 4 |
Molecular |
liver |
Mouse |
Plin4 |
29.0% Decrease Gene Expression Level |
|
| DAA636 |
Peptic ulcer |
Pathological |
stomach |
Human |
— |
SeriesMorbidity |
|
| DAA1970 |
Pdgfra (Platelete derived growth factor receptor a) mRNA levels decline |
Molecular |
pancreas |
Mouse |
Pdgfra |
— |
|
| DAA595 |
Pancreatic cancer |
Pathological |
pancreas |
Human |
— |
SeriesMorbidity |
|
| DAA1971 |
Pancreatic Beta-cell replication decrease |
Physiological |
pancreas |
Mouse |
— |
— |
|
| DAA1535 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
Molecular |
liver |
Mouse |
Nucks1 |
6.0% Increase Gene Expression Level |
|
| DAA860 |
Nonadrenergic innervation of myenteric plexus decreases |
Physiological |
jejunum |
Human |
— |
— |
|
| DAA857 |
Myenteric plexus neuron number decreases |
Physiological |
oesophagus, stomach, intestine |
Human |
— |
— |
|
| DAA857 |
Myenteric plexus neuron number decreases |
Physiological |
oesophagus, stomach, intestine |
Human |
— |
— |
|
| DAA857 |
Myenteric plexus neuron number decreases |
Physiological |
oesophagus, stomach, intestine |
Human |
— |
— |
|
| DAA1555 |
multiple coagulation factor deficiency 2 |
Molecular |
liver |
Mouse |
Mcfd2 |
Decrease Gene Expression Level |
|
| DAA831 |
Mouth becomes drier |
Physiological |
salivary gland |
Human |
— |
— |
|
| DAA2058 |
Mosaic abnormalities increase |
Physiological |
blood, oral cavity |
Human |
— |
— |
|
| DAA1530 |
mortality factor 4 like 2 |
Molecular |
liver |
Mouse |
Morf4l2 |
4.0% Increase Gene Expression Level |
|
| DAA854 |
More severe manifestations of gastroesophageal reflux disease |
Pathological |
oesophagus, stomach |
Human |
— |
— |
|
| DAA854 |
More severe manifestations of gastroesophageal reflux disease |
Pathological |
oesophagus, stomach |
Human |
— |
— |
|
| DAA1539 |
Moloney sarcoma oncogene |
Molecular |
liver |
Mouse |
Mos |
28.0% Decrease Gene Expression Level |
|
| DAA1534 |
mitochondrial ribosomal protein S12 |
Molecular |
liver |
Mouse |
Mrps12 |
5.0% Increase Gene Expression Level |
|
| DAA855 |
Migrating motor complex is prolonged |
Physiological |
small intestine |
Human |
— |
— |
|
| DAA1526 |
matrix metallopeptidase 14 (membrane-inserted) |
Molecular |
liver |
Mouse |
Mmp14 |
5.0% Increase Gene Expression Level |
|
| DAA1511 |
mannose-binding lectin (protein C) 2 |
Molecular |
liver |
Mouse |
Mbl2 |
4.0% Increase Gene Expression Level |
|